BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 21801808)

  • 1. Colonic vitamin D metabolism: implications for the pathogenesis of inflammatory bowel disease and colorectal cancer.
    Cross HS; Nittke T; Kallay E
    Mol Cell Endocrinol; 2011 Dec; 347(1-2):70-9. PubMed ID: 21801808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Vitamin D endocrine system of the gut--its possible role in colorectal cancer prevention.
    Cross HS; Bises G; Lechner D; Manhardt T; Kállay E
    J Steroid Biochem Mol Biol; 2005 Oct; 97(1-2):121-8. PubMed ID: 16081282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of vitamin D synthesis and catabolism in colorectal mucosa: a new target for cancer prevention.
    Cross HS; Nittke T; Peterlik M
    Anticancer Res; 2009 Sep; 29(9):3705-12. PubMed ID: 19667168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier.
    Kong J; Zhang Z; Musch MW; Ning G; Sun J; Hart J; Bissonnette M; Li YC
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G208-16. PubMed ID: 17962355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colonic epithelial cell proliferation decreases with increasing levels of serum 25-hydroxy vitamin D.
    Holt PR; Arber N; Halmos B; Forde K; Kissileff H; McGlynn KA; Moss SF; Kurihara N; Fan K; Yang K; Lipkin M
    Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):113-9. PubMed ID: 11815408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the colonic vitamin D system for prevention of tumor progression: an update.
    Cross HS; Kallay E
    Future Oncol; 2009 May; 5(4):493-507. PubMed ID: 19450178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysfunction of the vitamin D endocrine system as common cause for multiple malignant and other chronic diseases.
    Peterlik M; Cross HS
    Anticancer Res; 2006; 26(4A):2581-8. PubMed ID: 16886667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D physiology.
    Lips P
    Prog Biophys Mol Biol; 2006 Sep; 92(1):4-8. PubMed ID: 16563471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The roles of cytochrome P450 enzymes in prostate cancer development and treatment.
    Chen TC; Sakaki T; Yamamoto K; Kittaka A
    Anticancer Res; 2012 Jan; 32(1):291-8. PubMed ID: 22213318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of a potent and safe vitamin D receptor agonist for the treatment of inflammatory bowel disease.
    Laverny G; Penna G; Vetrano S; Correale C; Nebuloni M; Danese S; Adorini L
    Immunol Lett; 2010 Jun; 131(1):49-58. PubMed ID: 20350569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D.
    Dusso AS; Brown AJ; Slatopolsky E
    Am J Physiol Renal Physiol; 2005 Jul; 289(1):F8-28. PubMed ID: 15951480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The endocrine vitamin D system in the gut.
    Barbáchano A; Fernández-Barral A; Ferrer-Mayorga G; Costales-Carrera A; Larriba MJ; Muñoz A
    Mol Cell Endocrinol; 2017 Sep; 453():79-87. PubMed ID: 27913273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actions of vitamin D are mediated by the TLR4 pathway in inflammation-induced colon cancer.
    Murillo G; Nagpal V; Tiwari N; Benya RV; Mehta RG
    J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):403-7. PubMed ID: 20214986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of Inflammatory Bowel Disease and Colorectal Cancer by Synthetic Vitamin D Receptor Ligands.
    Takada I; Makishima M
    Curr Med Chem; 2017; 24(9):868-875. PubMed ID: 27915991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypergravity modulates vitamin D receptor target gene mRNA expression in mice.
    Ishizawa M; Iwasaki K; Kato S; Makishima M
    Am J Physiol Endocrinol Metab; 2009 Sep; 297(3):E728-34. PubMed ID: 19549793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1 alpha,25-Dihydroxyvitamin D(3) is a preventive factor in the metastasis of lung cancer.
    Nakagawa K; Kawaura A; Kato S; Takeda E; Okano T
    Carcinogenesis; 2005 Feb; 26(2):429-40. PubMed ID: 15539405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lymphatic system controls intestinal inflammation and inflammation-associated Colon Cancer through the chemokine decoy receptor D6.
    Vetrano S; Borroni EM; Sarukhan A; Savino B; Bonecchi R; Correale C; Arena V; Fantini M; Roncalli M; Malesci A; Mantovani A; Locati M; Danese S
    Gut; 2010 Feb; 59(2):197-206. PubMed ID: 19846409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
    J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium, vitamin D and cancer.
    Peterlik M; Grant WB; Cross HS
    Anticancer Res; 2009 Sep; 29(9):3687-98. PubMed ID: 19667166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal calcium transporter genes are upregulated by estrogens and the reproductive cycle through vitamin D receptor-independent mechanisms.
    Van Cromphaut SJ; Rummens K; Stockmans I; Van Herck E; Dijcks FA; Ederveen AG; Carmeliet P; Verhaeghe J; Bouillon R; Carmeliet G
    J Bone Miner Res; 2003 Oct; 18(10):1725-36. PubMed ID: 14584880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.